S. Plymate

Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease.

Suzanne Craft, Emily H. Trittschuh, S. Plymate, 2013, Journal of Alzheimer's disease : JAD.

Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial.

B. Gerton, G. Watson, P. Green, 2012, Archives of neurology.

Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment.

T. Montine, S. Craft, N. Postupna, 2011, Archives of neurology.

Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose.

J. Newcomer, S. Asthana, S. Plymate, 1999, Archives of general psychiatry.

Insulin Effects on Glucose Metabolism, Memory, and Plasma Amyloid Precursor Protein in Alzheimer's Disease Differ According to Apolipoprotein‐E Genotype

R. Martins, S. Asthana, E. Peskind, 2000, Annals of the New York Academy of Sciences.

Immunohistochemical localization of insulin-like growth factor binding proteins 2 and 3 in prostate tissue: clinical correlations.

J. Thrasher, S. Plymate, M. Tennant, 1996, The Journal of urology.

Insulin effects on CSF norepinephrine and cognition in Alzheimer's disease

Mark A. Reger, Sanjay Asthana, Lutz Frölich, 2006, Neurobiology of Aging.

Relationship between testosterone supplementation and insulin-like growth factor-I levels and cognition in healthy older men

A. Haley, S. Asthana, E. Peskind, 2004, Psychoneuroendocrinology.